Zepp Health Corporation (ZEPP)

NYSE: ZEPP · Real-Time Price · USD

13.26

-1.53 (-10.34%)

At close: Mar 25, 2026, 4:00 PM EDT

13.41

+0.15 (1.13%)

After-hours: Mar 25, 2026, 7:00 PM EDT

Zepp Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	258.9	182.6	352.86	613.64	983.87
Revenue Growth (YoY)	41.78%	-48.25%	-42.50%	-37.63%	-0.16%
Cost of Revenue	159.71	112.37	260.5	494.78	778.34
Gross Profit	99.19	70.23	92.36	118.86	205.53
Selling, General & Admin	83.1	71.33	71.31	103.42	109.66
Research & Development	45.32	46.16	51.5	77.3	81.08
Operating Expenses	128.42	117.48	122.81	180.71	190.74
Operating Income	-29.23	-47.25	-30.45	-61.86	14.79
Interest Expense	-5.7	-5.55	-6.75	-8.44	-7.07
Interest & Investment Income	1.53	3.67	3.09	1.82	2.63
Earnings From Equity Investments	-2.07	-4.21	1.11	2.68	6.46
Other Non Operating Income (Expenses)	0.06	-0.66	-0.53	6.45	4.32
EBT Excluding Unusual Items	-35.41	-54	-33.53	-59.35	21.12
Gain (Loss) on Sale of Investments	-2.12	-8.12	0.01	6.14	2.13
Pretax Income	-37.53	-62.12	-33.52	-53.21	23.25
Income Tax Expense	2.54	13.69	-2.43	-9.87	1.69
Earnings From Continuing Operations	-40.07	-75.81	-31.09	-43.35	21.56
Minority Interest in Earnings	-	0.08	0.07	0.1	0.13
Net Income	-40.07	-75.73	-31.02	-43.24	21.69
Net Income to Common	-40.07	-75.73	-31.02	-43.24	21.69
Net Income Growth	-	-	-	-	-38.09%
Shares Outstanding (Basic)	16	16	15	15	16
Shares Outstanding (Diluted)	16	16	15	15	17
Shares Change (YoY)	-1.72%	6.47%	-1.28%	-6.84%	1.54%
EPS (Basic)	-2.52	-4.68	-2.04	-2.81	1.38
EPS (Diluted)	-2.52	-4.68	-2.08	-2.88	1.31
EPS Growth	-	-	-	-	-39.27%
Free Cash Flow	-	-25.8	41.01	-118.32	-43.84
Free Cash Flow Per Share	-	-1.59	2.70	-7.69	-2.65
Gross Margin	38.31%	38.46%	26.17%	19.37%	20.89%
Operating Margin	-11.29%	-25.88%	-8.63%	-10.08%	1.50%
Profit Margin	-15.48%	-41.47%	-8.79%	-7.05%	2.21%
Free Cash Flow Margin	-	-14.13%	11.62%	-19.28%	-4.46%
EBITDA	-24.21	-42.23	-22.76	-53.15	22.96
EBITDA Margin	-9.35%	-23.13%	-6.45%	-8.66%	2.33%
D&A For EBITDA	5.02	5.02	7.69	8.71	8.17
EBIT	-29.23	-47.25	-30.45	-61.86	14.79
EBIT Margin	-11.29%	-25.88%	-8.63%	-10.08%	1.50%
Effective Tax Rate	-	-	-	-	7.27%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q